BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2457068)

  • 1. Location of a neutralizing epitope for the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus.
    Chambers P; Nesbit M; Yusoff K; Millar NS; Samson AC; Emmerson PT
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2115-22. PubMed ID: 2457068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of amino acid substitutions on glycosylation of the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus strain Beaudette C.
    Yusoff K; Nesbit M; Samson AC; Emmerson PT
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1549-52. PubMed ID: 2471815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation within a neutralizing domain on the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus.
    Iorio RM; Borgman JB; Glickman RL; Bratt MA
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1393-403. PubMed ID: 2425048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of haemagglutinin-neuraminidase antibody binding sites by Western blot analysis of antibody-resistant mutants and partial digest fragments of Newcastle disease virus.
    Samson AC; Nesbit M; Lyon AM; Meulemans G
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():473-80. PubMed ID: 3339333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural features unique to each of the three antigenic sites on the hemagglutinin-neuraminidase protein of Newcastle disease virus.
    Gotoh B; Sakaguchi T; Nishikawa K; Inocencio NM; Hamaguchi M; Toyoda T; Nagai Y
    Virology; 1988 Mar; 163(1):174-82. PubMed ID: 2450424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of sequence and haemagglutinin activity of the HN glycoprotein of Newcastle disease virus.
    Ke GM; Chuang KP; Chang CD; Lin MY; Liu HJ
    Avian Pathol; 2010 Jun; 39(3):235-44. PubMed ID: 20544431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning of complementary DNA to Newcastle disease virus, and nucleotide sequence analysis of the junction between the genes encoding the haemagglutinin-neuraminidase and the large protein.
    Chambers P; Millar NS; Bingham RW; Emmerson PT
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():475-86. PubMed ID: 3754000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of monoclonal antibody-resistant mutants of Newcastle disease virus.
    Samson AC; Russell PH; Hallam SE
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():357-61. PubMed ID: 3838186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide sequence analysis of the haemagglutinin-neuraminidase gene of Newcastle disease virus.
    Millar NS; Chambers P; Emmerson PT
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1917-27. PubMed ID: 3018130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parainfluenza virus type 2 haemagglutinin-neuraminidase glycoprotein characterized with monoclonal antibodies.
    Rydbeck R; Löve A; Orvell C
    J Gen Virol; 1988 Apr; 69 ( Pt 4)():931-5. PubMed ID: 2451708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avian cells expressing the Newcastle disease virus hemagglutinin-neuraminidase protein are resistant to Newcastle disease virus infection.
    Morrison TG; McGinnes LW
    Virology; 1989 Jul; 171(1):10-7. PubMed ID: 2545025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of three antigenic sites on the haemagglutinin-neuraminidase protein of Newcastle disease virus.
    Yusoff K; Nesbit M; McCartney H; Emmerson PT; Samson AC
    Virus Res; 1988 Nov; 11(4):319-33. PubMed ID: 2464879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anomalous behaviour of Newcastle disease virus haemagglutinin-neuraminidase protein in Western blotting analysis of monoclonal antibody binding sites.
    Samson AC
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1199-203. PubMed ID: 2423638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature-sensitive mutants of Newcastle disease virus altered in HN glycoprotein size, stability, or antigenic maturity.
    Peeples ME; Glickman RL; Gallagher JP; Bratt MA
    Virology; 1988 May; 164(1):284-9. PubMed ID: 3363869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment.
    Iorio RM; Glickman RL; Riel AM; Sheehan JP; Bratt MA
    Virus Res; 1989 Jul; 13(3):245-61. PubMed ID: 2475989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a potential neutralizing linear epitope of hemagglutinin-neuraminidase in Newcastle disease virus.
    Jin Z; Wei Q; Bi Y; Li Y; Huo N; Mou S; Wang W; Liu H; Yang Z; Chen H; Xiao S
    Virol J; 2021 Jan; 18(1):8. PubMed ID: 33407693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant infectious bursal disease virus expressing Newcastle disease virus (NDV) neutralizing epitope confers partial protection against virulent NDV challenge in chickens.
    Li K; Gao L; Gao H; Qi X; Gao Y; Qin L; Wang Y; Wang X
    Antiviral Res; 2014 Jan; 101():1-11. PubMed ID: 24200519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of reference strains of Newcastle disease virus (NDV) and NDV-like isolates by monoclonal antibodies to HN subunits.
    Ishida M; Nerome K; Matsumoto M; Mikami T; Oya A
    Arch Virol; 1985; 85(1-2):109-21. PubMed ID: 2409954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activities of monoclonal antibodies to the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus.
    Abenes GB; Kida H; Yanagawa R
    Nihon Juigaku Zasshi; 1986 Apr; 48(2):353-62. PubMed ID: 3712896
    [No Abstract]   [Full Text] [Related]  

  • 20. The characterization of monoclonal antibodies to Newcastle disease virus.
    Russell PH; Griffiths PC; Goswami KK; Alexander DJ; Cannon MJ; Russell WC
    J Gen Virol; 1983 Sep; 64 (Pt 9)():2069-72. PubMed ID: 6193248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.